Investigational drugs for pruritus

Bibliography

• Ständer S, Ständer H, Seeliger S, et al. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol 2007;156(5):1020-6
   PubMed Web of Science ®Google Scholar
• Ständer S, Stumpf A, Osada N, et al. Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol 2013;168(6):1273-80
   PubMed Web of Science ®Google Scholar
• Ständer S, Schäfer I, Phan NQ, et al. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology 2010;221(3):229-35
   PubMed Web of Science ®Google Scholar
• Kremer AE, Martens JJWW, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010;139(3):1008-18, 1018.e1
   PubMed Web of Science ®Google Scholar
• Alemi F, Kwon E, Poole DP, et al. The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest 2013;123(4):1513-30
   PubMed Web of Science ®Google Scholar
• Matsuda H, Watanabe N, Geba GP, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9(3):461-6
   PubMed Web of Science ®Google Scholar
• Tanaka A, Matsuda H. Evaluation of itch by using NC/NgaTnd mice: a model of human atopic dermatitis. J Biomed Biotechnol 2011;2011:790436
   PubMedGoogle Scholar
• Tanaka A, Amagai Y, Oida K, Matsuda H. Recent findings in mouse models for human atopic dermatitis. Exp Anim 2012;61(2):77-84
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Umakoshi K, Nojiri N, Kamei C. Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. Eur J Pharmacol 1998;351(1):1-5
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Oanta A, Bogacka E, et al. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. Allergy 2010;65(4):516-28
   PubMed Web of Science ®Google Scholar
• Hossen MA, Sugimoto Y, Kayasuga R, Kamei C. Involvement of histamine H3 receptors in scratching behaviour in mast cell-deficient mice. Br J Dermatol 2003;149(1):17-22
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Iba Y, Nakamura Y, et al. Pruritus-associated response mediated by cutaneous histamine H3 receptors. Clin Exp Allergy 2004;34(3):456-9
   PubMed Web of Science ®Google Scholar
• Bell JK, McQueen DS, Rees JL. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb/c mice. Br J Pharmacol 2004;142(2):374-80
   PubMed Web of Science ®Google Scholar
• Dunford PJ, Williams KN, Desai PJ, et al. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 2007;119(1):176-83
   PubMed Web of Science ®Google Scholar
• Cowden JM, Zhang M, Dunford PJ, Thurmond RL. The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Investig Dermatol 2009;130(4):1023-33
   PubMed Web of Science ®Google Scholar
• Rossbach K, Wendorff S, Sander K, et al. Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 2009;18(1):57-63
   PubMed Web of Science ®Google Scholar
• Bäumer W, Wendorff S, Gutzmer R, et al. Histamine H4 receptors modulate dendritic cell migration through skin–immunomodulatory role of histamine. Allergy 2008;63(10):1387-94
   PubMed Web of Science ®Google Scholar
• Gutzmer R, Mommert S, Gschwandtner M, et al. The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol 2009;123(3):619-25
   PubMed Web of Science ®Google Scholar
• Dijkstra D, Leurs R, Chazot P, et al. Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. J Allergy Clin Immunol 2007;120(2):300-7
   PubMed Web of Science ®Google Scholar
• Dijkstra D, Stark H, Chazot PL, et al. Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Invest Dermatol 2008;128(7):1696-703
   PubMed Web of Science ®Google Scholar
• Gschwandtner M, Rossbach K, Dijkstra D, et al. Murine and human Langerhans cells express a functional histamine H4 receptor: modulation of cell migration and function. Allergy 2010;65(7):840-9
   PubMed Web of Science ®Google Scholar
• Gschwandtner M, Mommert S, Kother B, et al. The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. J Invest Dermatol 2011;131(8):1668-76
   PubMed Web of Science ®Google Scholar
• Mommert S, Gschwandtner M, Koether B, et al. Human memory Th17 cells express a functional histamine H4 receptor. Am J Pathol 2012;180(1):177-85
   PubMed Web of Science ®Google Scholar
• Lazewska D, Kiec-Kononowicz K. Azines as histamine H4 receptor antagonists. Front Biosci (Schol Ed) 2012;4:967-87
   PubMedGoogle Scholar
• Shin N, Covington M, Bian D, et al. INCB38579, a novel and potent histamine H(4) receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions. Eur J Pharmacol 2012;675(1-3):47-56
   PubMed Web of Science ®Google Scholar
• Thurmond RL, Desai PJ, Dunford PJ, et al. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 2004;309(1):404-13
   PubMed Web of Science ®Google Scholar
• Kiss R, Keseru GM. Histamine H4 receptor ligands and their potential therapeutic applications: an update. Expert Opin Ther Pat 2012;22(3):205-21
   PubMed Web of Science ®Google Scholar
• Ohsawa Y, Hirasawa N. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy 2012;67(8):1014-22
   PubMed Web of Science ®Google Scholar
• Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther 2010;23(6):590-6
   PubMed Web of Science ®Google Scholar
• Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004;5(7):752-60
   PubMed Web of Science ®Google Scholar
• Diveu C, Lak-Hal AL, Froger J, et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur Cytokine Netw 2004;15(4):291-302
   PubMed Web of Science ®Google Scholar
• Takaoka A, Arai I, Sugimoto M, et al. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 2005;516(2):180-1
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117(2):411-17
   PubMed Web of Science ®Google Scholar
• Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol 2013;24(1):48-53. e11-2
   PubMed Web of Science ®Google Scholar
• Neis MM, Peters B, Dreuw A, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006;118(4):930-7
   PubMed Web of Science ®Google Scholar
• Takaoka A, Arai I, Sugimoto M, et al. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp Dermatol 2006;15(3):161-7
   PubMed Web of Science ®Google Scholar
• Ezzat MHM, Hasan ZE, Shaheen KYA. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring. J Eur Acad Dermatol Venereol 2011;25(3):334-9
   PubMed Web of Science ®Google Scholar
• Raap U, Weissmantel S, Gehring M, et al. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol 2012;23(3):285-8
   PubMed Web of Science ®Google Scholar
• Grimstad O, Sawanobori Y, Vestergaard C, et al. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 2009;18(1):35-43
   PubMed Web of Science ®Google Scholar
• Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C, Bigliardi-Qi M. Opioids and the skin–where do we stand? Exp Dermatol 2009;18(5):424-30
   PubMed Web of Science ®Google Scholar
• Phan NQ, Lotts T, Antal A, et al. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. Acta Derm Venerol 2012;92(5):555-60
   PubMed Web of Science ®Google Scholar
• Kuraishi Y, Yageta Y, Konno M, et al. Intracisternal, but not intrathecal, injection of naloxone inhibits cutaneous itch-related response in mice. Biol Pharm Bull 2008;31(11):2143-5
   PubMed Web of Science ®Google Scholar
• Inan S, Dun NJ, Cowan A. Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice. Neuroscience 2009;163(1):23-33
   PubMed Web of Science ®Google Scholar
• Liu X, Liu Z, Sun Y, et al. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 2011;147(2):447-58
   PubMed Web of Science ®Google Scholar
• Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM 2003;96(1):7-26
   PubMed Web of Science ®Google Scholar
• Dawn A, Yosipovitch G. Treating itch in psoriasis. Dermatol Nurs 2006;18(3):227-33
   PubMedGoogle Scholar
• Ko MCH, Song MS, Edwards T, et al. The role of central mu opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther 2004;310(1):169-76
   PubMed Web of Science ®Google Scholar
• Pan ZZ. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 1998;19(3):94-8
   PubMed Web of Science ®Google Scholar
• Carstens E, Akiyama T, Carstens MI. Differential itch- and pain-related behavioral responses and µ-opoid modulation in mice. Acta Derm Venerol 2010;90(6):575-81
   PubMed Web of Science ®Google Scholar
• Umeuchi H, Togashi Y, Honda T, et al. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol 2003;477(1):29-35
   PubMed Web of Science ®Google Scholar
• Kamei J, Nagase H. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol 2001;418(1-2):141-5
   PubMed Web of Science ®Google Scholar
• Togashi Y, Umeuchi H, Okano K, et al. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol 2002;435(2-3):259-64
   PubMed Web of Science ®Google Scholar
• Wakasa Y, Fujiwara A, Umeuchi H, et al. Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys. Life Sci 2004;75(24):2947-57
   PubMed Web of Science ®Google Scholar
• Umeuchi H, Kawashima Y, Aoki CA, et al. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride. Eur J Pharmacol 2005;518(2-3):133-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Tang K, Inan S, et al. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J Pharmacol Exp Ther 2005;312(1):220-30
   PubMed Web of Science ®Google Scholar
• Inan S, Cowan A. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacol Biochem Behav 2006;85(1):39-43
   PubMed Web of Science ®Google Scholar
• Nakao K, Ikeda K, Kurokawa T, et al. Effect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis. Nihon Shinkei Seishin Yakurigaku Zasshi 2008;28(2):75-83
   PubMedGoogle Scholar
• Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 2006;54(3):527-31
   PubMed Web of Science ®Google Scholar
• Lee H, Naughton NN, Woods JH, Ko M. Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology 2007;107(3):478-85
   PubMed Web of Science ®Google Scholar
• Phan NQ, Bernhard JD, Luger TA, Ständer S. Antipruritic treatment with systemic mu-opioid receptor antagonists: a review. J Am Acad Dermatol 2010;63(4):680-8
   PubMed Web of Science ®Google Scholar
• Wikstrom B, Gellert R, Ladefoged SD, et al. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 2005;16(12):3742-7
   PubMed Web of Science ®Google Scholar
• Kumagai H, Ebata T, Takamori K, et al. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 2010;25(4):1251-7
   PubMed Web of Science ®Google Scholar
• Inui S. Nalfurafine hydrochloride for the treatment of pruritus. Expert Opin Pharmacother 2012;13(10):1507-13
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen Z. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 2007;448(7154):700-3
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhao Z, Meng X, et al. Cellular basis of itch sensation. Science 2009;325(5947):1531-4
   PubMed Web of Science ®Google Scholar
• Yao R, Li T, Xu J, et al. Design, synthesis and anti-itch activity evaluation of aromatic amino acid derivatives as gastrin-releasing peptide receptor antagonists. Med Chem 2012;8(5):865-73
   PubMed Web of Science ®Google Scholar
• Liu T, Berta T, Xu Z, et al. TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice. J Clin Invest 2012;122(6):2195-207
   PubMed Web of Science ®Google Scholar
• Andoh T, Kuwazono T, Lee J, Kuraishi Y. Gastrin-releasing peptide induces itch-related responses through mast cell degranulation in mice. Peptides 2011;32(10):2098-103
   PubMed Web of Science ®Google Scholar
• Rukwied R, Lischetzki G, McGlone F, et al. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br J Dermatol 2000;142(6):1114-20
   PubMed Web of Science ®Google Scholar
• Tanaka A, Matsuda H. Expression of nerve growth factor in itchy skins of atopic NC/NgaTnd mice. J Vet Med Sci 2005;67(9):915-19
   PubMed Web of Science ®Google Scholar
• Groneberg DA, Serowka F, Peckenschneider N, et al. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 2005;161(1-2):87-92
   PubMed Web of Science ®Google Scholar
• Albers KM, Wright DE, Davis BM. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J Neurosci 1994;14(3 Pt 2):1422-32
   PubMed Web of Science ®Google Scholar
• Takano N, Sakurai T, Ohashi Y, Kurachi M. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model. Br J Dermatol 2007;156(2):241-6
   PubMed Web of Science ®Google Scholar
• Negi O, Tominaga M, Tengara S, et al. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis. J Dermatol Sci 2012;66(1):37-43
   PubMed Web of Science ®Google Scholar
• Matsuda A, Tanaka A, Pan W, et al. Supplementation of the fermented soy product ImmuBalance effectively reduces itching behavior of atopic NC/Tnd mice. J Dermatol Sci 2012;67(2):130-9
   PubMed Web of Science ®Google Scholar
• Ikezawa Z, Komori J, Ikezawa Y, et al. A role of Staphyococcus aureus, interleukin-18, nerve growth factor and semaphorin 3A, an axon guidance molecule, in pathogenesis and treatment of atopic dermatitis. Allergy Asthma Immunol Res 2010;2(4):235-46
   PubMedGoogle Scholar
• Taneda K, Tominaga M, Negi O, et al. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. Br J Dermatol 2011;165(2):277-84
   PubMed Web of Science ®Google Scholar
• Kou K, Nakamura F, Aihara M, et al. Decreased expression of semaphorin-3A, a neurite-collapsing factor, is associated with itch in psoriatic skin. Acta Derm Venereol 2012;92(5):521-8
   PubMed Web of Science ®Google Scholar
• Wallengren J, Ekman R, Sundler F. Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol 1987;67(3):185-92
   PubMed Web of Science ®Google Scholar
• Pincelli C, Fantini F, Massimi P, et al. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990;122(6):745-50
   PubMed Web of Science ®Google Scholar
• Chan J, Smoller BR, Raychauduri SP, et al. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 1997;289(11):611-16
   PubMed Web of Science ®Google Scholar
• Andoh T, Nagasawa T, Satoh M, Kuraishi Y. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 1998;286(3):1140-5
   PubMed Web of Science ®Google Scholar
• Brain SD. New feelings about the role of sensory nerves in inflammation. Nat Med 2000;6(2):134-5
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Vergnolle N, Young SH, et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000;6(2):151-8
   PubMed Web of Science ®Google Scholar
• Kuraishi Y, Nagasawa T, Hayashi K, Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 1995;275(3):229-33
   PubMed Web of Science ®Google Scholar
• Ikoma A, Steinhoff M, Ständer S, et al. The neurobiology of itch. Nat Rev Neurosci 2006;7(7):535-47
   PubMed Web of Science ®Google Scholar
• Andoh T, Katsube N, Maruyama M, Kuraishi Y. Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice. J Invest Dermatol 2001;117(6):1621-6
   PubMed Web of Science ®Google Scholar
• Kanai H, Nagashima A, Hirakata E, et al. The effect of azelastin hydrochloride on pruritus and leukotriene B4 in hemodialysis patients. Life Sci 1995;57(3):207-13
   PubMed Web of Science ®Google Scholar
• Andoh T, Kuraishi Y. Inhibitory effects of azelastine on substance P-induced itch-associated response in mice. Eur J Pharmacol 2002;436(3):235-9
   PubMed Web of Science ®Google Scholar
• Bozic CR, Lu B, Hopken UE, et al. Neurogenic amplification of immune complex inflammation. Science 1996;273(5282):1722-5
   PubMed Web of Science ®Google Scholar
• Costa SKP, Starr A, Hyslop S, et al. How important are NK1 receptors for influencing microvascular inflammation and itch in the skin? Studies using Phoneutria nigriventer venom. Vascul Pharmacol 2006;45(4):209-14
   PubMed Web of Science ®Google Scholar
• Cuellar JM, Jinks SL, Simons CT, Carstens E. Deletion of the preprotachykinin A gene in mice does not reduce scratching behavior elicited by intradermal serotonin. Neurosci Lett 2003;339(1):72-6
   PubMed Web of Science ®Google Scholar
• Lee JH, Cho SH. Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: an atopic dermatitis model. J Ethnopharmacol 2011;133(2):810-17
   PubMed Web of Science ®Google Scholar
• Quartara L, Altamura M. Tachykinin receptors antagonists: from research to clinic. Curr Drug Targets 2006;7(8):975-92
   PubMed Web of Science ®Google Scholar
• Chang S, Han S, Jung H, Choi J. Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol 2007;156(6):1272-7
   PubMed Web of Science ®Google Scholar
• Ständer S, Siepmann D, Herrgott I, et al. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One 2010;5(6):e10968
   PubMed Web of Science ®Google Scholar
• Akiyama T, Tominaga M, Davoodi A, et al. Roles for substance P and gastrin-releasing peptide as neurotransmitters released by primary afferent pruriceptors. J Neurophysiol 2013;109(3):742-8
   PubMed Web of Science ®Google Scholar
• Benecke H, Wäring J, Lotts T, Ständer S. Transient receptor potential channels and pruritus. In: Szallasi A, Bíró T, editors. TRP channels in drug discovery: volume II. Springer, Human Press; New York, Heidelberg: 2012. p. 255-78
   Google Scholar
• Imamachi N, Park GH, Lee H, et al. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci USA 2009;106(27):11330-5
   PubMed Web of Science ®Google Scholar
• Ständer S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 2002;11(1):12-24
   PubMed Web of Science ®Google Scholar
• Bíró T, Toth BI, Marincsak R, et al. TRP channels as novel players in the pathogenesis and therapy of itch. Biochim Biophys Acta 2007;1772(8):1004-21
   PubMed Web of Science ®Google Scholar
• Shim W, Tak M, Lee M, et al. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 2007;27(9):2331-7
   PubMed Web of Science ®Google Scholar
• Kim S, Park GH, Kim D, et al. Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proc Natl Acad Sci USA 2011;108(8):3371-6
   PubMed Web of Science ®Google Scholar
• Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389(6653):816-24
   PubMed Web of Science ®Google Scholar
• Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000;288(5464):306-13
   PubMed Web of Science ®Google Scholar
• Bíró T, Maurer M, Modarres S, et al. Characterization of functional vanilloid receptors expressed by mast cells. Blood 1998;91(4):1332-40
   PubMed Web of Science ®Google Scholar
• Denda M, Fuziwara S, Inoue K, et al. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem Biophys Res Commun 2001;285(5):1250-2
   PubMed Web of Science ®Google Scholar
• Inoue K, Koizumi S, Fuziwara S, et al. Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem Biophys Res Commun 2002;291(1):124-9
   PubMed Web of Science ®Google Scholar
• Ständer S, Moormann C, Schumacher M, et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 2004;13(3):129-39
   PubMed Web of Science ®Google Scholar
• Basu S, Srivastava P. Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells. Proc Natl Acad Sci USA 2005;102(14):5120-5
   PubMed Web of Science ®Google Scholar
• Bodó E, Bíró T, Telek A, et al. A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 2005;166(4):985-98
   PubMed Web of Science ®Google Scholar
• Mishra SK, Hoon MA. The cells and circuitry for itch responses in mice. Science 2013;340(6135):968-71
   PubMed Web of Science ®Google Scholar
• Tominaga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998;21(3):531-43
   PubMed Web of Science ®Google Scholar
• Szallasi A, Blumberg PM. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 1989;30(2):515-20
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Bienenstock J, Schmelz M, et al. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006;126(8):1705-18
   PubMed Web of Science ®Google Scholar
• Wallengren J, Klinker M. Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 1995;32(2 Pt 1):287-9
   PubMed Web of Science ®Google Scholar
• Ständer S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001;44(3):471-8
   PubMed Web of Science ®Google Scholar
• Jessell TM, Iversen LL, Cuello AC. Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res 1978;152(1):183-8
   PubMed Web of Science ®Google Scholar
• Dallos A, Kiss M, Polyanka H, et al. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides 2006;40(4):251-63
   PubMed Web of Science ®Google Scholar
• Raap U, Ständer S, Metz M. Pathophysiology of itch and new treatments. Curr Opin Allergy Clin Immunol 2011;11(5):420-7
   PubMed Web of Science ®Google Scholar
• Belghiti M, Estevez-Herrera J, Gimenez-Garzo C, et al. Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease. J Biol Chem 2013;288(14):9675-85
   PubMed Web of Science ®Google Scholar
• Inagaki N, Shiraishi N, Igeta K, et al. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur J Pharmacol 2006;546(1-3):189-96
   PubMed Web of Science ®Google Scholar
• Breneman DL, Cardone JS, Blumsack RF, et al. Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 1992;26(1):91-4
   PubMed Web of Science ®Google Scholar
• Ellis CN, Berberian B, Sulica VI, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993;29(3):438-42
   PubMed Web of Science ®Google Scholar
• Green BG, Shaffer GS. The sensory response to capsaicin during repeated topical exposures: differential effects on sensations of itching and pungency. Pain 1993;53(3):323-34
   PubMed Web of Science ®Google Scholar
• Nolano M, Simone DA, Wendelschafer-Crabb G, et al. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 1999;81(1-2):135-45
   PubMed Web of Science ®Google Scholar
• Liang J, Ji Q, Ji W. Role of transient receptor potential ankyrin subfamily member 1 in pruritus induced by endothelin-1. Neurosci Lett 2011;492(3):175-8
   PubMed Web of Science ®Google Scholar
• Kim D, Kim H, Sung K, et al. 12(S)-HPETE induces itch-associated scratchings in mice. Eur J Pharmacol 2007;554(1):30-3
   PubMed Web of Science ®Google Scholar
• Kim D, Kim H, Kim H, et al. Involvement of serotonin receptors 5-HT1 and 5-HT2 in 12(S)-HPETE-induced scratching in mice. Eur J Pharmacol 2008;579(1-3):390-4
   PubMed Web of Science ®Google Scholar
• Kim AY, Tang Z, Liu Q, et al. Pirt, a phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1. Cell 2008;133(3):475-85
   PubMed Web of Science ®Google Scholar
• Patel KN, Liu Q, Meeker S, et al. Pirt, a TRPV1 modulator, is required for histamine-dependent and -independent itch. PLoS One 2011;6(5):e20559
   PubMedGoogle Scholar
• Ständer S, Metze D. Treatment of pruritic skin diseases with topical capsaicin. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F, editors. Itch: basic mechanisms and therapy. Marcel Dekker; New York, Basel: 2004. p. 287-304
   Google Scholar
• Gooding SMD, Canter PH, Coelho HF, et al. Systematic review of topical capsaicin in the treatment of pruritus. Int J Dermatol 2010;49(8):858-65
   PubMed Web of Science ®Google Scholar
• Yun J, Seo JA, Jang W, et al. Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models. J Invest Dermatol 2011;131(7):1576-9
   PubMed Web of Science ®Google Scholar
• Yun J, Seo JA, Jeong YS, et al. TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. J Dermatol Sci 2011;62(1):8-15
   PubMed Web of Science ®Google Scholar
• Lim K, Park Y. Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases. Arch Pharm Res 2012;35(3):393-6
   PubMed Web of Science ®Google Scholar
• Sekine R, Satoh T, Takaoka A, et al. Anti pruritic effects of topical crotamiton, capsaicin, and a corticosteroid on pruritogen-induced scratching behavior. Exp Dermatol 2012;21(3):201-4
   PubMed Web of Science ®Google Scholar
• Akopian AN, Ruparel NB, Patwardhan A, Hargreaves KM. Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. J Neurosci 2008;28(5):1064-75
   PubMed Web of Science ®Google Scholar
• Xiao B, Patapoutian A. Scratching the surface: a role of pain-sensing TRPA1 in itch. Nat Neurosci 2011;14(5):540-2
   PubMed Web of Science ®Google Scholar
• Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004;41(6):849-57
   PubMed Web of Science ®Google Scholar
• Jordt S, Bautista DM, Chuang H, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 2004;427(6971):260-5
   PubMed Web of Science ®Google Scholar
• Bautista DM, Movahed P, Hinman A, et al. Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci USA 2005;102(34):12248-52
   PubMed Web of Science ®Google Scholar
• Bautista DM, Jordt S, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006;124(6):1269-82
   PubMed Web of Science ®Google Scholar
• Macpherson LJ, Hwang SW, Miyamoto T, et al. More than cool: promiscuous relationships of menthol and other sensory compounds. Mol Cell Neurosci 2006;32(4):335-43
   PubMed Web of Science ®Google Scholar
• Story GM, Peier AM, Reeve AJ, et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 2003;112(6):819-29
   PubMed Web of Science ®Google Scholar
• Dai Y, Wang S, Tominaga M, et al. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Invest 2007;117(7):1979-87
   PubMed Web of Science ®Google Scholar
• Tsujii K, Andoh T, Lee J, Kuraishi Y. Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice. J Pharmacol Sci 2008;108(3):385-8
   PubMed Web of Science ®Google Scholar
• Liu T, Ji R. Oxidative stress induces itch via activation of transient receptor potential subtype ankyrin 1 in mice. Neurosci Bull 2012;28(2):145-54
   PubMed Web of Science ®Google Scholar
• Wilson SR, Gerhold KA, Bifolck-Fisher A, et al. TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch. Nat Neurosci 2011;14(5):595-602
   PubMed Web of Science ®Google Scholar
• Costa R, Marotta DM, Manjavachi MN, et al. Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. Br J Pharmacol 2008;154(5):1094-103
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003;23(15):6176-80
   PubMed Web of Science ®Google Scholar
• Shimada SG, Shimada KA, Collins JG. Scratching behavior in mice induced by the proteinase-activated receptor-2 agonist, SLIGRL-NH2. Eur J Pharmacol 2006;530(3):281-3
   PubMed Web of Science ®Google Scholar
• Liu Q, Weng H, Patel KN, et al. The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia. Sci Signal 2011;4(181):ra45
   PubMed Web of Science ®Google Scholar
• Shim W, Oh U. Histamine-induced itch and its relationship with pain. Mol Pain 2008;4:29
   PubMedGoogle Scholar
• Han JH, Choi H, Kim SJ. Topical TRPM8 agonist (icilin) relieved vulva pruritus originating from lichen sclerosus et atrophicus. Acta Derm Venereol 2012;92(5):561-2
   PubMed Web of Science ®Google Scholar
• Bíró T, Ko MC, Bromm B, et al. How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol 2005;14(3):225-40
   PubMed Web of Science ®Google Scholar
• Bharate SS, Bharate SB. Modulation of thermoreceptor TRPM8 by cooling compounds. ACS Chem Neurosci 2012;3(4):248-67
   PubMed Web of Science ®Google Scholar
• McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002;416(6876):52-8
   PubMed Web of Science ®Google Scholar
• Peier AM, Moqrich A, Hergarden AC, et al. A TRP channel that senses cold stimuli and menthol. Cell 2002;108(5):705-15
   PubMed Web of Science ®Google Scholar
• Cho Y, Jang Y, Yang YD, et al. TRPM8 mediates cold and menthol allergies associated with mast cell activation. Cell Calcium 2010;48(4):202-8
   PubMed Web of Science ®Google Scholar
• Medic N, Desai A, Komarow H, et al. Examination of the role of TRPM8 in human mast cell activation and its relevance to the etiology of cold-induced urticaria. Cell Calcium 2011;50(5):473-80
   PubMed Web of Science ®Google Scholar
• Weisshaar E, Szepietowski JC, Darsow U, et al. European guideline on chronic pruritus. Acta Derm Venereol 2012;92(5):563-81
   PubMed Web of Science ®Google Scholar
• Ständer S, Darsow U, Mettang T, et al. S2k guideline–chronic pruritus. J Dtsch Dermatol Ges 2012;10(Suppl 4):S1-27
   PubMed Web of Science ®Google Scholar
• Vincenzi B, Tonini G, Santini D. Aprepitant for erlotinib-induced pruritus. N Engl J Med 2010;363(4):397-8
   PubMed Web of Science ®Google Scholar
• Santini D, Vincenzi B, Guida FM, et al. Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study. Lancet Oncol 2012;13(10):1020-4
   PubMed Web of Science ®Google Scholar
• Duval A, Dubertret L. Aprepitant as an antipruritic agent? N Engl J Med 2009;361(14):1415-16
   PubMed Web of Science ®Google Scholar
• Booken N, Heck M, Nicolay JP, et al. Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 2011;164(3):665-7
   PubMed Web of Science ®Google Scholar
• Torres T, Fernandes I, Selores M, et al. Aprepitant: evidence of its effectiveness in patients with refractory pruritus continues. J Am Acad Dermatol 2012;66(1):e14-15
   PubMed Web of Science ®Google Scholar
• Vincenzi B, Fratto ME, Santini D, Tonini G. Aprepitant against pruritus in patients with solid tumours. Support Care Cancer 2010;18(9):1229-30
   PubMed Web of Science ®Google Scholar